1. 成都中医药大学临床医学院
2. 成都中医药大学附属医院
纸质出版:2016
移动端阅览
[1]郭强,赵欢,雷星星,祝然然,朱玉霞,杨东东,陈秋.丹红注射液联合常规疗法治疗糖尿病合并脑梗死患者临床疗效及安全性Meta分析[J].中医杂志,2016,57(02):131-135.
GUO Qiang, ZHAO Huan, LEI Xingxing, et al. Meta Analysis on Clinical Curative Effect and Safety of Danhong Injection(丹红注射液) Combined with Routine Therapy in Treating Patients Suffering from Diabetes with Cerebral Infarction[J]. Journal of Traditional Chinese Medicine2016, 57(2): 131-135.
[1]郭强,赵欢,雷星星,祝然然,朱玉霞,杨东东,陈秋.丹红注射液联合常规疗法治疗糖尿病合并脑梗死患者临床疗效及安全性Meta分析[J].中医杂志,2016,57(02):131-135. DOI: 10.13288/j.11-2166/r.2016.02.011.
GUO Qiang, ZHAO Huan, LEI Xingxing, et al. Meta Analysis on Clinical Curative Effect and Safety of Danhong Injection(丹红注射液) Combined with Routine Therapy in Treating Patients Suffering from Diabetes with Cerebral Infarction[J]. Journal of Traditional Chinese Medicine2016, 57(2): 131-135. DOI: 10.13288/j.11-2166/r.2016.02.011.
目的系统评价丹红注射液联合常规疗法治疗糖尿病合并脑梗死患者的临床疗效及安全性。方法检索MEDLINE、EMBASE、The Cochrane Library、中国期刊全文数据库、中国生物医学文献数据库、万方数字化期刊全文数据库和中文科技期刊数据库
检索截止日期为2014年12月。纳入丹红注射液联合常规疗法治疗糖尿病合并脑梗死的随机对照试验研究
提取患者一般资料、干预措施、结局指标等信息
采用偏倚风险评估工具对纳入研究进行方法学质量评价
并对临床总有效率及神经功能缺损评分进行Meta分析。结果最终纳入9项临床研究
涉及782例患者。Meta分析结果显示
与常规疗法比较
丹红注射液联合常规疗法可提高糖尿病合并脑梗死患者的临床总有效率[RR=1.29
95%CI(1.13
1.48)
Z=3.70
P=0.0002
3篇文献];与其他中药注射液联合常规疗法比较
丹红注射液联合常规疗法可提高糖尿病合并脑梗死患者的临床总有效率[RR=1.30
95%CI(1.14
1.47)
Z=4.03
P<0.001
4篇文献];与西药注射液联合常规疗法比较
丹红注射液联合常规疗法可提高糖尿病合并脑梗死患者的临床总有效率[RR=1.23
95%CI(1.09
1.40)
Z=3.27
P=0.001
2篇文献]。与常规疗法比较
丹红注射液联合常规疗法可减少糖尿病合并脑梗死患者的神经功能缺损评分[MD=-4.94
95%CI(-6.31
-3.57)
Z=7.06
P<0.001
1篇文献];与其他中药注射液联合常规疗法比较
丹红注射液联合常规疗法可减少糖尿病合并脑梗死患者的神经功能缺损评分[MD=-5.07
95%CI(-7.40
-2.73)
Z=4.25
P<0.001
2篇文献];与西药注射液联合常规疗法比较
丹红注射液联合常规疗法可减少糖尿病合并脑梗死患者的神经功能缺损评分[MD=-5.08
95%CI(-6.89
-3.27)
Z=5.49
P<0.001
1篇文献]。纳入研究均未报告由丹红注射液引起的严重不良反应。结论丹红注射液联合常规疗法可提高糖尿病合并脑梗死患者的临床有效率、减少神经功能缺损
但确切结论尚需更多高质量研究加以验证。
Objective To systematically evaluate the clinical curative effect and safety of Danhong Injection( 丹红注射液) combined with routine therapy in treating patients suffering from diabetes with cerebral infarction. Methods Databases such as MEDLINE
EMBase
the Cochrane Library
Chinese Journals Full-Text Database
Chinese Biological and Medical Database
Wanfang China Online Journals
and Chinese Science and Technology Periodical Database were searched until December 2014. Randomized controlled trials on Danhong Injection combined with routine therapy treating patients suffering from diabetes with cerebral infarction were collected. General information of patients
as well as data on intervening measure and outcome indicator were extracted. Risk of bias evaluation tools were adopted to conduct quality evaluation on methodology of the researches included. Meta analysis was conducted on total clinical effective rate and neurological severity scores. Results Eventually 9 clinical studies were included
including 782 cases of patients. Results by Meta analysis indicated that
compared with routine therapy
Danhong Injection combined with routine therapy could increase total clinical effective rate of patients suffering from diabetes with cerebral infarction [RR = 1. 29
95% CI( 1. 13
1. 48)
Z = 3. 70
P = 0. 0002
3 articles]; Compared with other herbs combined with routine therapy
Danhong Injection combined with routine therapy could increase total clinical effective rate of patients suffering from diabetes with cerebral infarction [RR = 1. 30
95% CI( 1. 14
1. 47)
Z =4. 03
P < 0. 001
4 articles]; Compared with western medicine combined with routine therapy
Danhong Injection combined with routine therapy could increase total clinical effective rate of patients suffering from diabetes with cerebral infarction [RR = 1. 23
95% CI( 1. 09
1. 40)
Z = 3. 27
P = 0. 001
2 articles]; Compared with routine therapy
Danhong Injection combined with routine therapy could decrease neurological severity scores of patients suffering from diabetes with cerebral infarction [MD =- 4. 94
95% CI(- 6. 31
- 3. 57)
Z = 7. 06
P < 0. 001
1 articles]; Compared with other herbs combined with routine therapy
Danhong Injection combined with routine therapy could decrease neurological severity scores of patients suffering from diabetes with cerebral infarction [MD =- 5. 07
95% CI(- 7. 40
- 2. 73)
Z = 4. 25
P < 0. 001
2 articles]; Compared with western medicine combined with routine therapy
Danhong Injection combined with routine therapy could decrease neurological severity scores of patients suffering from diabetes with cerebral infarction [MD =- 5. 08
95% CI(- 6. 89
- 3. 27)
Z =5. 49
P < 0. 001
1 articles]; No serious adverse reaction arising from Danhong Injection was reported in the researches included in. Conclusion Danhong Injection combined with routine therapy could increase clinical effective rate and decrease neurological severity scores of patients suffering from diabetes with cerebral infarction. But definite conclusion remains to be examined by more high-quality studies.
0
浏览量
747
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号